In a substantial move for India's pharmaceutical manufacturing sector, Sun Pharmaceutical Industries has committed to an investment of Rs 3,800 crore in Madhya Pradesh, creating an estimated 2,000 new jobs...
In a significant advancement for artificial intelligence technology's application to public health, Rajasthan's MadhuNetr DR-AI programme, which uses AI to assist screening for diabetic retinopathy, has received approval by the government for...
.jpeg){kind=spacer}
Scientists at the Indian Council of Medical Research (ICMR) expect that the phase-III clinical trial of DengiAll, developed as the first ever indigenous dengue vaccine of India, will reach the enrollment of about 10,500 people by October 2025.
In a significant shift in mosquito-borne disease trends, Chikungunya cases have now surpassed Dengue in Bhopal, raising red flags over possible underreporting and gaps in surveillance. As of July 2025, the city has continuted to have equally...
In a significant move towards the evolution of military healthcare logistics, the Armed Forces Medical Services (AFMS) is investigating the feasibility of using drones for transportation of blood bags, medicines and emergency supplies, to remote...
.jpg)
Pharma major Cipla is preparing to enter India's weight management space as a part of its strategy to leverage emerging healthcare opportunities and niche therapy opportunities.
An organization that promotes exports stated that a new law that centralizes the licensing procedure for medicine exports through a web portal might reduce shipments by over 45%, asking for time to transition to the new system.
.jpeg)
Maharashtra reported a slight rise in fresh COVID-19 cases as the state recorded seven new cases on Friday, bringing the number of cases since January 1 to 2,620. Mumbai remains the primary area of the outbreak, recording four of the new cases...
India’s pharmaceutical sector is focused on a major goal of increasing exports to USD 1 trillion, and biosimilars are emerging as the cornerstone of this growth. Currently valued at USD 50–55 billion, pharmaceutical exports from India are expected...
In a bold strategic shift, Wockhardt has divested its U.S. generics business to focus on high-value, innovative therapies, including novel antibiotics and biologics. The company announced the voluntary liquidation of Wockhardt USA LLC and Morton...
, CDSCO.jpg)
